Publications by authors named "Elina Parri"

Claim this Profile
S
Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells.
Elina Parri, Heikki Kuusanmäki, Daria Bulanova, Satu Mustjoki, Krister Wennerberg

Blood Adv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel regulators of STAT3 activity.
Elina Parri, Heikki Kuusanmäki, Arjan J van Adrichem, Meri Kaustio, Krister Wennerberg

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies.
Balaguru Ravikumar, Sanna Timonen, Zaid Alam, Elina Parri, Krister Wennerberg

Cell Chem Biol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras-driven lung tumours.
Katja Närhi, Ashwini S Nagaraj, Elina Parri, Riku Turkki, Petra W van Duijn

J Pathol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.
Jing Tang, Zia-Ur-Rehman Tanoli, Balaguru Ravikumar, Zaid Alam, Anni Rebane, Elina Parri

Cell Chem Biol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
Heikki Kuusanmäki, Olli Dufva, Elina Parri, Arjan J van Adrichem, Hanna Rajala

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors.
Anna Cichonska, Balaguru Ravikumar, Elina Parri, Sanna Timonen, Tapio Pahikkala

PLoS Comput Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis